Axon Enterprise, INC Form 4 insider transactions
NASDAQ
Director Michael Garnreiter sold 1,000 shares of Axon Enterprise, Inc. on August 16, 2024, at a price of $374.99 per share, according to a Form 4 filing with the SEC.
NASDAQ
Axon Enterprise's COO & CFO, Brittany Bagley, sold shares of common stock on August 15, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Director Matthew R. McBrady reported selling shares of Axon Enterprise, Inc. in multiple transactions on August 9, 2024.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, disposed of shares to cover tax liabilities from vesting restricted stock units.
NASDAQ
Joshua Isner, President of Axon Enterprise, sold shares of common stock on June 18, 2024, under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ
Joshua Isner, President of Axon Enterprise, disposed of 1,077 shares of common stock on June 14, 2024, to cover tax liabilities from vesting restricted stock units.
NASDAQ
Director Julie A. Cullivan sold 993 shares of Axon Enterprise, Inc. at a price of $281.72 per share on May 31, 2024, under a pre-arranged 10b5-1 trading plan.
NASDAQ
Director Julie A. Cullivan sold 478 shares of Axon Enterprise, Inc. on May 28, 2024, at a price of $286.04 per share.
NASDAQ
Caitlin Elizabeth Kalinowski, a director at Axon Enterprise, Inc., sold 2,000 shares of common stock at an average price of $290.1934 on May 20, 2024.
NASDAQ
Director Adriane M. Brown reports acquisition of restricted stock units in Axon Enterprise, Inc.
NASDAQ
Director Caitlin Elizabeth Kalinowski reports acquiring 657 shares of Axon Enterprise, Inc. common stock through time-vested restricted stock units.
NASDAQ
Michael Garnreiter, a director of Axon Enterprise, Inc., reported the acquisition of restricted stock units on May 10, 2024.
NASDAQ
Director Julie A. Cullivan reported the acquisition of restricted stock units in Axon Enterprise, Inc. on May 10, 2024.
NASDAQ
Director Matthew McBrady acquired 657 shares of Axon Enterprise, Inc. common stock on May 10, 2024.
NASDAQ
Director Graham Smith acquired 657 shares of Axon Enterprise common stock through time-vested restricted stock units.
NASDAQ
Director Hadi Partovi reports acquiring 657 shares of Axon Enterprise common stock through time-vested restricted stock units.
NASDAQ
Director Erika Nardini acquired 657 shares of Axon Enterprise common stock in the form of restricted stock units, vesting fully by the company's 2025 annual meeting.
NASDAQ
Director Jeri Williams reports a sale of 308 shares and acquisition of 657 restricted stock units of Axon Enterprise stock.
NASDAQ
Jeffrey Kunins, CPO & CTO of Axon Enterprise, executed multiple sales of common stock on May 9, 2024, at prices ranging from $308.81 to $312.7850.
NASDAQ
Axon Enterprise's President, Joshua Isner, executed multiple sales of common stock on May 9, 2024, at prices ranging from $307.80 to $312.73.
NASDAQ
Cameron Brooks, Chief Revenue Officer of Axon Enterprise, Inc., reports the acquisition of 23,715 restricted stock units.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, disposed of shares to cover tax liabilities from vesting restricted stock units.
NASDAQ
Brittany Bagley, COO & CFO of Axon Enterprise, reports the acquisition of 3,213 restricted stock units that will vest on September 7, 2024.
NASDAQ
Joshua Isner, President of Axon Enterprise, reports acquiring 10,279 shares of common stock on March 14, 2024, through time-vested restricted stock units.
NASDAQ
Jeffrey Kunins, CPO & CTO of Axon Enterprise, reports the acquisition of 2,185 restricted stock units that will vest on September 7, 2024.